A general observation of our data was that patterns of HR significance were maintained among both CD4+ and CD8+ TIL populations for anatomical subsites, indicating that tumor location is a greater discriminating factor than T-cell subset in HNSCC. The gene discussed is CD4; the disease is neoplasm.